About Us

Mission Statement

The mission of the Sarcomeric Human Cardiomyopathy Registry (SHaRe) is to build a community of cardiovascular geneticists and research-based cardiologists who have in common a profound dedication to helping patients with heritable heart disease. By collaboratively expanding the knowledge base, SHaRe will generate fresh insights and research initiatives with the ultimate goal of supporting the development of novel therapies where none exist today.

SHaRe's vision is to create hope for the future for those diagnosed with heritable forms of cardiomyopathy through research.

Beyond the hospital

The physicians within SHaRe know that specialized healthcare goes beyond the people you work with at the hospital. True healthcare is a team approach involving the patient and their family, their community, researchers, pharmaceuticals, and their team of doctors. It’s a complete picture of a complicated issue. It’s the way healthcare should work and it’s the way the SHaRe investigators are determined to make it work.

Community insights

Through family histories, clinical characteristics, imaging and laboratory data, we will gain insights into genetic and environmental contributions to cardiomyopathy.

Further understanding

SHaRe aims to advance the understanding of Hypertrophic and Dilated Cardiomyopathy. By harmonizing and pooling detailed, longitudinal genetic and clinical data from experienced investigators across many centers of excellence, this registry will not only be larger, but also better than what has come before.

Better predict

Better understanding clinical predictors and outcomes will allow us to test current wisdom and to generate more accurate predictors of risk and disease progression. We will begin to overcome historic limitations, critically re-defining phenotype and modifiers of outcome in sarcomeric cardiomyopathies.


333 Allerton Avenue
South San Francisco, CA, 94080
Share – From Care to Cure